At a glance
- Originator Shionogi
- Class Anti-ischaemics; Antiasthmatics
- Mechanism of Action Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Myocardial infarction